Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)

NACompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2016

Conditions
Schizophrenia
Interventions
DRUG

amisulpride

Individually dosed, according to symptoms, for a period of 6 weeks

DRUG

aripiprazole

Individually dosed, according to symptoms, for a period of 6 weeks

Trial Locations (1)

DK-2600

Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup, Glostrup Municipality

Sponsors
All Listed Sponsors
collaborator

Glostrup University Hospital, Copenhagen

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Institute of Psychiatry, London

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Copenhagen Hospital Corporation

OTHER

lead

University of Copenhagen

OTHER

NCT01154829 - Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) | Biotech Hunter | Biotech Hunter